DEAD-box proteins are enzymes endowed with nucleic acid-dependent ATPase, RNA translocase and unwinding activities. The human DEAD-box protein DDX3 has been shown to play important roles in tumor proliferation and viral infections. In particular, DDX3 has been identified as an essential cofactor for HIV-1 replication. Here we characterized a set of DDX3 mutants biochemically with respect to nucleic acid binding, ATPase and helicase activity. In particular, we addressed the functional role of a unique insertion between motifs I and Ia of DDX3 and provide evidence for its implication in nucleic acid binding and HIV-1 replication. We show that human DDX3 lacking this domain binds HIV-1 RNA with lower affinity. Furthermore, a specific peptide ligand for this insertion selected by phage display interferes with HIV-1 replication after transduction into HelaP4 cells. Besides broadening our understanding of the structure-function relationships of this important protein, our results identify a specific domain of DDX3 which may be suited as target for antiviral drugs designed to inhibit cellular cofactors for HIV-1 replication.
Introduction
The DEAD-box proteins constitute a subfamily of the DExD/ H-box RNA helicases within the helicase superfamily 2 [1] . They are named after the amino acid sequence of the Walker B motif Asp-Glu-Ala-Asp (D-E-A-D), which is conserved in all members of the subfamily. The DEAD-box protein family comprises proteins found in all eukaryotes and most prokaryotes. Their widespread conservation is related to their essential roles in almost all aspects of RNA metabolism, from transcription, splicing and decay, to translation [2] [3] [4] . DEAD-box proteins are endowed with nucleic acid-dependent ATPase activity and some also show ATPdependent RNA unwinding. While they differ in the amino acid (aa) sequence in their extreme N-and C-terminal parts, they all contain a core helicase domain, which is composed of two covalently linked globular domains (subdomain 1, aa 168-405 and subdomain 2, aa 411-582 in DDX3) each consisting of five bstrands and five a-helices, connected by a flexible linker (aa 406-410 in DDX3). Based on sequence alignments, nine conserved motifs have been identified in the helicase core of DEAD-box proteins. Motifs I (Walker A), II (Walker B) III and Q of the subdomain 1, together with motifs V and VI of subdomain 2, are directly involved in ATP binding and hydrolysis. Motifs Ia and Ib of subdomain 1 together with motifs IV, -[QxxR]-and V of subdomain 2 are involved in RNA binding [1] . Based on the available crystal structures of several DEAD box helicases showing the spatial arrangements of both domains, also in complex with RNA and nucleotides, a model has been proposed for the coordinated interplay of both subdomains in nucleic acid binding and ATP hydrolysis [5] . In the absence of bound ATP and nucleic acid, the DEAD-box proteins adopt open conformations, whereby subdomains 1 and 2 are separated from each other. On the other hand, the structures of the Vasa protein from D. melanogaster, human Dbp5 and DDX19, showed a closed conformation, with both subdomains creating an RNA binding surface and contributing to the ATP binding site [5] [6] [7] . Binding of ATP has been proposed to facilitate the interaction of the a-helix 8 of motif I with a conserved Arg in motif V, creating the RNA-binding competent conformation [5] .
The DEAD-box ATPase/RNA helicase DDX3 has recently been in the focus of intense research, owing to its implications in tumor proliferation and viral infections [8] [9] [10] [11] [12] . In particular, DDX3 has been shown as an essential cofactor for human immunodeficiency virus type 1 (HIV-1) replication [13] . Functional genomic screenings have recently identified about 300 human proteins important for the replicative cycle of HIV-1 [14] . Such previously unrecognized complexity of host-pathogen relationships, coupled to the seemingly unavoidable problem of drug resistance due to the high mutation rate of HIV-1, has renewed the long-standing interest toward cellular proteins as novel targets for the treatment of HIV-1 infection. The main argument in favor of targeting a host factor instead of a viral protein is the predicted low drug resistance level. On the other hand, interfering with a cellular pathway might lead to serious complications, including crucial cell function loss or oncogenic drift. Thus, it is of paramount importance to identify host cellular factors and to characterize the domains that, while essential for virus replication, are dispensable for the host cell metabolism. The protein DDX3 apparently satisfies all the requirements of a potential anti-HIV target, and we have recently shown that small molecule inhibitors of DDX3 ATPase activity can block HIV-1 replication [12] .
In order to design even more selective inhibitors of DDX3, a detailed knowledge of its biochemical properties is essential. DDX3 has been shown to have both ATPase and RNA helicase activities and to possess a rather relaxed nucleotide substrate specificity, being able to accept as substrates both ribo-and deoxynucleoside triphosphates, as well as different nucleotide analogs [11, 15, 16] . The core helicase domain (aa 132-605) of human DDX3 is nearly identical to X. laevis An3 and M. musculus Pl10 proteins and has strong homology to the corresponding domain of the yeast Ded1 and Dbp1 proteins [17] . Recently, the core domain of human DDX3 has been crystallized in complex with AMP [18] . In the absence of bound RNA, the protein adopts an open conformation. However, by analogy with other DEAD-box protein structures, it has been proposed that also DDX3 would adopt a closed conformation once bound to ATP and RNA.
Human DDX3 has been reported to have a unique region between motifs I and Ia, which has been proposed to bind the 39-end of the RNA substrate [18] . Such an insertion is also conserved in the closest homologs of DDX3 (Fig. 1 A) . Sequence alignment analysis, revealed that the length of the amino acid sequence between motifs I and Ia is very similar among different DEAD-box proteins, being about 30 aa in representative human, insect, yeast and archeal proteins (Fig. 1 B) . Among all eukaryotic DEAD-box proteins available in the databases, only three members appear to have longer insertions: DDX3 (42 aa), DDX42 (150 aa) and DDX1, this latter with the longest insertion of 240 aa. Sequence alignment of this region of DDX3 and other DEAD-box proteins, revealed a high degree of identity for the sequences immediately flanking the motifs I and Ia (Fig. 1 C) , while the central part was more variable. Interestingly, the human proteins showed an invariant -[DG]-motif in common with DDX3, while proteins with more distant phylogenetic relationship (Drosophila Vasa, T. thermophilus Hera, S. cerevisiae Dbp9) lacked such a motif, but showed a -[ExG]-conserved box. The Vasa and Hera proteins also have in common with DDX3 an additional basic amino acid -[ExGR]-in this box. DDX3, however, was unique in having an additional positively charged extension -[YGRRK]-. By using a series of different DDX3 mutants (Fig. 1 D) , we show here that the central 10 residues of the DDX3 insertion (aa 250-259) are important for the ATPase activity, nucleic acid binding and unwinding. We also found that in vitro human DDX3 can unwind partially double stranded (ds) DNA substrates with a preference for 59-single strand DNA overhangs, a property previously shown only for the S.cerevisiae Dbp9 member of the DEAD box proteins [19] . Finally, we show that the DDX3 unique region of the insertion between motifs I and Ia contributes to HIV-1 RNA binding and, furthermore, that a specific peptide ligand to this region reduces the ability of DDX3 to support HIV-1 replication in infected cells.
Taken together, our results uncovered novel unique features of human DDX3, which might be used to design novel selective anti-HIV agents.
Results

Construction, purification and ATPase activity determination of human DDX3 mutants
To study the role of the DDX3 specific insertion between motifs I and Ia, a deletion mutant, DDX3DINS, lacking aa 250-259 ( Fig. 1 D and Materials and Methods) was constructed, starting from the cDNA for full length human DDX3. We also produced the N-DDX3 mutant lacking the C-terminus (D428-662) and consisting of the entire subdomain 1 plus the linker domain and the double deletion mutant I-DDX3 (D1-159/ D428-662), corresponding to the helicase core of subdomain 1. Isolated domain 1 from different DEAD-box helicases has been successfully crystallized, indicating that the two domains can properly fold individually. Moreover, a multiple construct approach applied to DDX3 has previously shown that constructs lacking the first 169 aa were perfectly expressed as soluble proteins [18] . In addition, the single point mutant K230E, bearing a substitution in motif I (Walker A); and the double mutant DADA (D346A/D349A), bearing a double mutation in motif II (Walker B) were also constructed. The residues mutated in these proteins are known to be essential for ATP binding and hydrolysis [6, 13] , which allowed us to include these loss-offunction mutants as controls to rule out the presence of any possible contaminating ATPase activity, as well as ATPindependent DNA unwinding activities. We also cloned the full length human DEAD-box protein DDX1, bearing the largest known insertion between motifs I and Ia. The corresponding cDNAs were cloned into the pTRcHis expression vector and expressed in E. coli as N-terminal his-tagged fusion proteins. The recombinant proteins were soluble and purified through four subsequent chromatographic steps, as described in Materials and Methods, involving affinity chromatography (Ni-NTA), anion-(MonoQ) and cation-(MonoS) exchange chromatography and hydroxyapatite (HAP) column.
As an example, Fig. 2 A shows the eluted peak fractions of DDX3wt from the last column (HAP). The protein in the fractions was recognized by specific anti-human DDX3 polyclonal Abs (Fig. 2 B) . Fractions 20-26 (indicated with asterisks) were pooled and used for the experiments. Fig. 2 C shows the SDS-PAGE of all the other DDX3 proteins after purification. Next, the intrinsic ability of all the purified proteins to hydrolyze ATP in the absence of nucleic acid was tested. As shown in Fig. 2 4) . Surprisingly, the isolated subdomain 1 of DDX3, either full (N-DDX3, lane 3) or lacking the first 160 aa (I-DDX3, lane 7) also displayed low but detectable ATPase activity. To verify that ATP hydrolysis was catalyzed by the truncated mutants, and not due to a contaminant, we tested the sensitivity of the N-DDX3 mutant towards FE15, a specific inhibitor of DDX3 ATPase previously developed in our laboratory [12] . As shown in Fig. 2 E and F, ATP hydrolysis of both DDX3wt and the N-DDX3 mutant was inhibited by the compound FE15 with similar potency. To verify whether the introduced deletion could significantly alter the folding of the DDX3DINS mutant, thermal inactivation experiments were carried out. As shown in Fig. 2 G and H, DDX3DINS was about 2-fold more resistant to thermal inactivation than the wild type protein, as suggested by the time-dependent activity decay at 70uC. These results indicate that the specific 10 aa insertion of DDX3 likely plays a structural role, but is not essential for the intrinsic ATPase activity of the protein.
The DDX3 insertion between motifs I and Ia is required for stimulation of ATPase activity by DNA and RNA. We have previously shown that the ATPase activity of wild type human DDX3 could be stimulated to a similar extent by a variety of different hetero-and homopolymeric nucleic acids (NA), irrespectively of their sequence or base composition, the main difference being the nature of the ribose sugar (RNA vs. DNA) [15] . Thus, we compared the ability of NA (both DNA and RNA) to stimulate the ATPase activity of the different DDX3 proteins. Addition of single strand (ss) RNA or DNA in the presence of DDX3wt clearly stimulated ATP hydrolysis (Fig. 3 A-C) . The calculated kinetic parameters are reported in Table 1 . DDX3 showed a higher apparent affinity for ATP (lower K m ) as compared to that of most DEAD-box proteins [1] . The catalytic efficiency (k cat /K m ) of DDX3wt was increased 2.8-and 3.2-fold by RNA and DNA, respectively (Table 1 and Fig. 3 H) . The comparable stimulation of DDX3 ATPase by RNA and DNA was uncommon, since most DEAD-box proteins analyzed to date showed a preference for RNA vs. DNA as a cofactor of their ATPase activity [1] . The DDX3DINS mutant (lacking aa 250-259), showed a lower affinity for ATP than DDX3wt (Table 1) , while its catalytic rate was similar. In order to assess whether the K m value determined from the variation of ATP hydrolysis rate as a function of substrate concentration, truly reflected a difference in ATP binding, we measured the apparent equilibrium dissociation constant (K D ) of ATP for DDX3wt and DDX3DINS, in the absence of catalysis, by directly UV-crosslinking [a 33 P]-ATP to the enzyme active site (Fig. 3 F) . As shown in Fig. 3 G and Table 1 , the K D value for ATP was 2.8-fold higher for the DDX3DINS mutant than for DDX3wt, confirming a lower binding affinity of ATP for this mutant. The stimulation of the basal ATPase activity (k cat /K m ) of this mutant by both RNA and DNA was lower than with the wt enzyme ( Table 1 and Fig. 3 H) , being less than 2-fold. These data suggest a possible role of the deleted domain in mediating the interaction with NA and with ATP, likely keeping the Walker A and B motifs correctly aligned for ATP binding. As shown in Fig. 3 E, increasing the DDX3DINS concentration from 0.15 mM to 0.5 mM did not result in better stimulation by either Figure 1 . Human DDX3 has a unique insertion between motifs I and Ia. A and motif Ia of human DDX3 (accession n. NP001347) with S. cerevisiae Ded1p (accession n. P06634), S. cerevisiae Dbp1 (accession n. P2478), S. pombe Ded1 (accession n. O13370), M. musculus Pl10 (accession n. NP149068) and X. laevis An3 (accession n. NP001095245) proteins. Identical/equivalent amino acids are shaded. Residues of the conserved motifs are in bold. The DDX3 specific insertion is indicated with a black box. Multiple alignments were performed with the program ClustalW2 (www.ebi.ac.uk/Tools/clustalw2). B. Schematic representation of the length of the insertion sequences between motifs I and Ia of DDX3 and different DEAD-box proteins. The number of amino acids in each insertion is indicated. C. Multiple sequence alignment of the region between motif I and Ia of DDX3 and different DEAD-box proteins. Identical amino acids are shaded in dark grey, equivalent amino acids are shaded in light grey. Basic amino acids in the DDX3 insertion are in bold. Multiple alignments were performed with the program ClustalW2 (www.ebi.ac.uk/Tools/clustalw2). D. Schematic representation of the different mutants used in this study. The conserved motifs are named after their consensus sequence and represented as boxes. The name of the different mutants is on the left of the panel, while the corresponding amino acids are indicated on the right side, along with the corresponding biochemical properties revealed in this study. +, 100% (basal activity); ++, +++, stimulation of basal activity; +/2, reduced basal activity; 2, no activity. Boxed residues in motifs I and II of the K230E and DADA mutants identify the single amino acid changes. doi:10.1371/journal.pone.0019810.g001 DNA or RNA. The N-and I-DDX3 mutants (lacking the entire subdomain 2), on the other hand, showed no stimulation of the ATPase activity in the presence of both NA (Table 1 and Fig. 3 F) . As summarized in Table 1 , the N-and I-DDX3 mutants also showed 3-to 9-fold reduced catalytic efficiency for ATP hydrolysis with respect to DDX3wt in the absence of NA. These data indicate that the isolated DDX3 subdomain 1 still retains a very low basal ATPase activity, while the presence of both subdomains is essential for full catalytic efficiency and stimulation by NA.
We also compared the ability of nucleic acids to stimulate the ATPase activity of the human DDX1 protein, that bears a long insertion (250 aa) between motifs I and Ia, but shows no similarity within this region with the equivalent region of DDX3. As shown in Table 1 , the catalytic efficiency of DDX1 was stimulated 2.6-fold by RNA, but only 1.3-fold by DNA, as typically observed for DEAD-box proteins. Thus, the high degree of stimulation by DNA observed with DDX3 was not simply due to a wider distance between motifs I and Ia with respect to the majority of DEAD-box proteins ( Fig. 1 B) , but rather to sequence/structure-specific determinants.
The DDX3 insertion between motifs I and Ia is important for DNA binding. In order to better characterize the ability of DNA to stimulate the ATPase activity of DDX3, the ATP hydrolysis rate was measured in the presence of increasing ssDNA concentrations. A typical experiment is shown in Fig. 4 A. Doseresponse curves were generated by measuring the variation of the reaction velocity as a function of increasing ssDNA concentrations, in the presence of a fixed amount of ATP (Fig. 4 B) . For each data point, the corresponding relative -fold increase values (12v DNA /v) were plotted as a function of the nucleic acid concentrations and fitted to a hyperbolic relationship (see Materials and Methods). As shown in Fig. 4 B, the DDX3DINS mutant protein showed a significant reduction (3.2-fold) in the maximal stimulation of the ATPase activity by ssDNA, with respect to DDX3wt.
Next, the ATPase reaction of DDX3wt and the DDX3DINS mutant proteins was monitored at different time points in the absence or presence of both nucleic acids (NA) ssRNA and ssDNA. The corresponding progress curves were fitted to a mixed exponential equation (as detailed in Materials and Methods) as a function of time. This analysis allowed to estimate three parameters: the burst amplitude (A burst ), which is proportional to the amount (expressed as a concentration) of the enzymesubstrates E:(NA):ATP complex formed at the beginning of the reaction; the burst rate (k burst ) which represents the global rate of conversion of the E:(NA):ATP complex into the E:ADP complex and the steady-state rate (k ss ), which is the limiting rate of the reaction at equilibrium (likely Pi release and NA dissociation). Thus, the effects of nucleic acids addition on the early steps of the reaction can be estimated by the variations of A burst and k burst values. Progress curves for DDX3wt and DDX3DINS are shown in Fig. 4 C and D. The calculated values are summarized in Table 2 . Addition of RNA or DNA caused a 3-to 3.6-fold increase in A burst values for DDX3wt. On the contrary, both RNA and DNA caused a smaller increase in the burst amplitude of the DDX3DINS mutant (1.8-to 2-fold increase). The k burst of DDX3wt was also increased by nucleic acid addition (1.7-to 2.3-fold increase), while no effect on the k burst for DDX3DINS was observed in the presence of DNA or RNA. The N-and I-DDX3 mutants showed reduced A burst and k burst values for ATP hydrolysis, with respect to wild type DDX3 in the absence of nucleic acids, indicating that the subdomain 1 alone was severely impaired both in binding and in hydrolysis of ATP. This is consistent with the important roles that residues in motifs V and VI are known to play in the formation of the ATP binding site. Neither DNA nor RNA had any effect on both A burst and k burst for the N-or I-DDX3 mutants, according to their loss of stimulation by NA.
Collectively, these results indicate that deletion of the specific DDX3 insert between motifs I and Ia reduced the formation of the enzyme-NA complex. In contrast, lack of the C-terminal subdomain 2 completely abrogated NA interaction.
From the curves shown in Fig. 4 B, the apparent affinity (K app ) value for ssDNA was 3.3-fold higher for DDXDINS compared to DDX3wt, suggestive of a reduced affinity for the nucleic acid. This K app value, however, has been derived as a function of the ATP hydrolysis rate, thus being related to the concentration of ternary enzyme-DNA-ATP complex that has reacted with ATP and not directly to the enzyme-DNA binary complex formed. To further verify that the DDX3DINS had a reduced binding affinity for nucleic acids also in the absence of catalysis, an electrophoretic mobility shift assay was performed, in the presence of various amounts of DDX3wt or DDX3DINS and a fixed dose of a 59-labelled ssRNA or ssDNA oligonucleotides. As shown in Fig. 4 E and F, the DDX3DINS was less efficient in binding RNA and DNA, respectively, with respect to DDX3wt, as judged by the lower amount of enzyme-NA complex formed (compare lanes 2-5 with lanes 6-9 in both panels E and F). Since DDX3 is also a helicase (see also below), dsRNA or DNA is also a physiological substrate. Thus, nitrocellulose filter-binding assays (Fig. 4 G) were performed to measure the affinity of DDX3wt and DDX3DINS to dsDNA, in the absence of ATP hydrolysis. As shown in Fig. 4 H, the DDX3DINS mutant showed a 2.1-fold reduced affinity for dsDNA, in agreement with the proposed role of the specific DDX3 insert in NA interaction.
The human DDX3 specific insert is important for the RNA helicase activity Human DDX3 was shown to possess an ATP-dependent RNA helicase activity [12, 13, 15] . The ability of the different DDX3 mutants to unwind a double-strand (ds) RNA heteropolymeric template was therefore compared. As shown in Fig. 5 A, DDX3wt (lanes 1-6) showed more efficient RNA helicase activity than the DDX3DINS mutant (lanes 9-14). The previous experiments (Fig. 4 and Table 2 ), suggested that this mutant had an impaired RNA binding. To test whether this reduced affinity for RNA was the cause of the reduced helicase activity, the same experiments were performed under single-turnover conditions, i.e. in the presence of a 50-fold molar excess of unlabelled ssRNA as a trap. Under these conditions, as soon as the enzyme dissociates from the duplex substrate, it should be sequestered by the competitor RNA preventing rebinding to the labelled substrate. As shown in Fig. 5 B, while DDX3wt (lanes 1-6) was still able to unwind the RNA duplex in the presence of the trap, the activity of the DDX3DINS mutant (lanes 9-14) was almost completely inhibited in the presence of the competitor RNA. This suggests that the complex between this mutant and the RNA duplex had a significantly reduced half-life with respect to the wt enzyme, becoming sequestered by the competitor ssRNA before it could initiate the unwinding reaction. The corresponding progress curves are shown in Fig. 5 C and the calculated apparent rates of unwinding (k uw ) are reported in Table 3 . Addition of the trap reduced the unwinding rate of DDX3wt by about 2-fold, suggesting that under distributive conditions (i.e. without trap) DDX3wt required two binding events in order to fully displace the 18mer strand from the complementary 36mer. In the absence of the trap, the DDX3DINS mutant showed a 2-fold reduced unwinding rate with respect to DDX3wt, while addition of the trap caused a 10-fold reduction in the unwinding rate (Table 3) . Thus, the DDX3DINS mutant was significantly impaired in its RNA unwinding activity. As expected, the isolated subdomain 1 (N-or I-DDX3) did not show helicase activity (data not shown). These results clearly indicate that both subdomains are required for helicase activity and that the DDX3 insertion between motifs I and Ia is important for interaction with RNA.
Human DDX3 can unwind partially double-stranded DNA with 59-single strand overhangs. The ability of the human DDX3 ATPase to be significantly stimulated by DNA prompted us to investigate whether the enzyme was able to unwind ds DNA substrates. To this aim, we employed three pairs of partially complementary DNA oligonucleotides, to generate partially dsDNA substrates with either 59-or a 39-protruding ss ends, or both (Fig. 6 A) . The shorter oligo was 59-labelled with a fluorescent group (FAM). Helicase reactions were carried out in the presence of ATP and the products resolved on non-denaturing PAGE. Human DDX3wt was able to unwind a DNA duplex carrying both 59-and 39-protruding ssDNA ends (Fig. 6 A, lanes 1-5) or with a single 59-protruding end (lanes 11-15), but not the substrate with a 39-ss DNA region (lanes 6-10). As expected, mutants lacking ATPase activity (K230E and DADA) or DNA binding (Nand I-DDX3) were found to be inactive also as DNA helicases (data not shown). The mutant DDX3DINS showed DNA helicase activity, but much lower than DDX3wt (compare Fig. 6 A, lanes 3-5, with Fig. 6 B, lanes 7-9), consistent with its reduced affinity for DNA (shown in Fig. 4 ). Human DDX1, similarly to most DEAD-box helicases, did not display DNA unwinding capability (Fig. 6 B, lanes 3-5) . Taken together, these data suggest that lack of the specific DDX3 insert (aa 250-259) causes a reduction in DNA unwinding, while the mere presence of a long insertion between motifs I and Ia (as is the case for DDX1) did not suffice to confer DNA helicase activity.
The DDX3 specific insertion is important for the function of DDX3 as a cofactor of HIV-1 replication. A role for DDX3 in the export of HIV-1 unspliced RNA, in cooperation with the vial protein Rev and the cellular protein XPO1/CRM1 has been proposed [13] . In order to analyze the effect of the DDX3 specific insertion in view of this role of DDX3 as cellular cofactor for HIV-1 replication, we first performed HIV-1 RNA pulldown experiments, using viral genomic RNA prepared from HIV-1 virions with equal amounts of purified DDX3wt and DDX3DINS proteins. Bound viral RNA was quantified by RT-PCR of a fragment corresponding to the gag gene. Fig. 7 A summarizes the results of three independent experiments. Clearly, To further analyze the role of the DDX3 insertion in the context of HIV-1 replication, we selected peptide ligands for the DDX3 insertion from phage displayed random peptide libraries. Interestingly, one of the selected peptides, DDX3-INS1, showed amino acid homologies to XPO1/CRM1, a natural binding partner of DDX3 that is involved in the export of unspliced HIV-1 RNA in conjunction with the viral Rev protein (Fig. 7 B) . We therefore analyzed this peptide further, with respect to functional interference with HIV-1 replication. After fusion to a protein transduction domain, different amounts of the DDX3-INS1 peptide or a control peptide were transduced into HelaP4 cells 24 hours after infection with HIV-1Lai. HIV-1 infection was quantified 48-72 hours after infection by titering released HIV-1 in culture supernatants on Tzm-bl cells based on measuring the luciferase activity in the cell lysates. As shown in Fig. 7C , the DDX3-INS1 peptide reduces HIV-1 replication about 50% at 20 mM in contrast to the control peptide. The DDX3-INS1 peptide was not toxic for the cells in the concentration range used (data not shown). Thus, binding of the peptide ligand to the DDX3 insertion, interferes with HIV-1 replication further providing evidence of an important functional role of the DDX3 insertion not only for enzymatic functions, but also for HIV-1 replication.
Discussion
Human DDX3 was co-crystallized with AMP in the absence of nucleic acid and thus the available structure represents the ''open'' conformation of the protein, as opposed to the ''closed'' conformation observed for other DEAD box proteins in complex with RNA, which involves repositioning of subdomains 1 and 2 relative to each other to accommodate both RNA and ATP substrates [18] . This fact, together with the presence of AMP and not ATP in the binding site of DDX3, did not allow to establish a role of domains V and VI in mediating the interactions with the band c-phosphates of the nucleotide as seen in the RNA-bound structures of the VASA protein of D. melanogaster [6] or the human Dbp5 [7] . Our results showed that the isolated subdomain 1 alone (mutant N-DDX3 aa 1-427) of human DDX3 possesses a low but detectable intrinsic (i.e., nucleic acid-independent) ATPase activity. This finding is apparently in contrast with the reported lack of ATPase activity of the entire DDX3 helicase core (aa 168-582) used for crystallization [18] . It is possible that the isolated subdomain 1 might fold more easily into a catalytically active globular domain.
On the basis of the structures of Vasa and Dbp5 [6, 7] , it has been proposed that a conserved aromatic residue (F or Y) of motif VI (-GRF/YG-) stacks on the purine ring of adenosine, thus contributing to its binding. Sequence alignment showed that this residue is not conserved in DDX3, where it is replaced by a valine (-GRVG-). On the other hand, the conserved aromatic residue of the Q-motif, which stacks also on top of the purine ring, is conserved in DDX3 (Y201). A metal ion is coordinated to the band c-phosphates of ATP, through essential water molecules which are contacted by the invariant aspartic acid of Walker B and a glycine residue of motif VI. Both these residues are also conserved in DDX3 and, based on the overall high homology between the conserved motifs of Vasa and DDX3, they have been proposed to play a similar role as seen in Vasa [18] . Other specific contacts of subdomain 2 include the ribose (motif V) and the triphosphate moiety (motif VI) of ATP. However, the structures of Vasa and Dbp5 clearly indicated that the majority of the interactions, including those occurring with the water molecules, are mediated by residues of motifs Q, I, II and III, all confined in the N-terminal subdomain 1. Since a structure for DDX3 in its closed conformation is lacking, it is possible that the DDX3 Both the ATPase and nucleic acid binding activities of the DEAD-box proteins are functionally connected to their helicase activity. In this respect, DEAD-box proteins are considered to behave more as ATP-dependent RNA binding proteins, than classical helicases, since ATP binding/hydrolysis does not generate energy for translocation, but rather drives the conformational changes required to destabilize the double helix [20] [21] [22] [23] . Based on the DDX3 crystal structure, it has been proposed that the specific . We have experimentally proven this hypothesis by showing that the DDX3 mutant lacking this particular insertion has a seriously compromised RNA and DNA ATPase stimulation and unwinding activity. In addition, the deleted insertion likely plays some structural role in defining the architecture of the ATP binding site, since the DDX3DINS mutant displayed reduced ATP binding with respect to DDX3 full length. We found that human DDX3, contrary to most DEAD-box helicases, can unwind partially dsDNA substrates with a preference for DNA substrates containing a 59-single stranded overhang. DNA unwinding by a DEAD-box protein has been shown so far only for the Dpb9 protein of S. cerevisiae [19] . The strong preference for RNA by DEAD-box proteins has been ascribed to four specific ribose 29-OH contacts, mediated by five amino acids in motifs Ia, Ib and IV, as seen in the Vasa crystal structure. Sequence alignment of human DDX3, S. cerevisiae Dpb9, human DDX1, Drosophila Vasa and human Dbp5 (Fig. 6 C) , showed that the residues in motif Ia and Ib are conserved in all proteins, irrespectively of their RNA vs. DNA preference, while the glutamic acid residue of motif IV is present only in DDX3 and Vasa. Thus, it seems that the presence of these residues did not suffice to confer an absolute preference for RNA vs DNA to DEAD box proteins. A model of DDX3 in the closed conformation bound to RNA, based on the Vasa-RNA complex structure, suggested that the specific DDX3 insertion between motifs I and Ia, contributes to generate a positively charged cavity in the close proximity of the 39-end of the bound nucleic acid [18] . The 59-strand loading preference observed for DDX3 DNA unwinding implies that the annealed strand is displaced starting from its 39-end (Fig. 6 A) . It is then tempting to speculate that the unique DDX3 insertion might partially contribute to the 59-end loading preference of DDX3. It is interesting to note that the human protein DDX1, which bears a very large insertion (250 aa) between motifs I and Ia, has a clear preference for RNA as an activator for its ATPase and does not show DNA helicase activity (Fig. 4 A and 6 B) .
Furthermore, we could experimentally prove that the DDX3 insertion functionally contributes to the cofactor activity of DDX3 with respect to HIV-1 replication (Fig. 7) . First, lack of the insertion in DDX3DINS reproducibly resulted in reduced pull down of HIV-1 genomic RNA compared to DDX3wt as detected by RT-PCR. Second, a specific peptide ligand, selected from phage display libraries with a DDX3-derived peptide containing the insertion, was shown to interfere with replication of HIV-1 Lai in HelaP4 cells. Interestingly, the selected peptide showed extensive homology to XPO1/CRM1, a natural binding partner of DDX3 involved in nuclear export of unspliced HIV RNAs in conjunction with Rev. It is possible that, by binding to the insertion between domains I and Ia of DDX3, the peptide prevented the correct assembly of the DDX3/CRM1/Rev/HIV-RNA complex, required for nuclear export. Additional experiments with optimized peptides have to further elucidate if, indeed, interference with viral replication occurs at the level of RNA export from the nucleus. In fact, a recent study revealed a role of DDX3 also in the translation of HIV-1 proteins [24] .
In summary, we have provided evidence for a role of the unique motif located in the DDX3 N-terminal subdomain 1 in ATPase activity, nucleic acid binding and HIV-1 cofactor activity of DDX3. Given the interest of DDX3 as a possible target for antiviral chemotherapy, the design of small molecules specifically interacting with this DDX3 unique motif might be considered.
Materials and Methods
Nucleic Acids
The PCR primers, the oligo(dT) 20 and oligo(rU) 20 used for the stimulation of the ATPase activity and the DNA oligonucleotides used for the helicase assays were synthesized by MWG-Biotech (Florence, Italy) and PAGE purified.RNA oligonucleotide sequences were:r18mer_FAM: 59CCCAAGAACCCAAGGAAC-39r36mer:59ACCAGCUUUGUUCCUUGGGUUCUUGGGAGCA-GCAGG-39. The r36 mer oligonucleotide bears a sequence complementary to the 18 mer (in italic). The r18 mer was labelled at its 59 end with a fluorescent group (6-FAM).
DNA oligonucleotide sequences were:d18mer_FAM:59CT-CAACTCAACCCTTCAT-39d38mer_central:59AATATTGAG-GATGAAGGGTTGAGTTGAGTGGAGATAGT-39d38mer_59: 59ATGAAGGGTTGAGTTGAGTGGAGATAGTGGAGGGTAG-T-39d38mer_39:59GGAGGGTAGGAATATTGAGGATGAAG-
GGTTGAGTTGAG-39
The 38 mer oligonucleotides bear a sequence complementary to the 18 mer (in italic) at different positions. The 18 mer was labelled at its 59 end with a fluorescent group (6-FAM).
Chemicals
[c-32 P] ATP (3000Ci/mmol) was from GE Healthcare. [a-33 P] ATP (3000Ci/mmol) was from Hartmann Analytic GmbH. Unlabelled ATP was from Sigma. All other reagents were of analytical grade and purchased from Merck or Fluka.
Cloning of human DDX3
The human DDX3 coding sequence was cloned from PBMC cells as described [15] .
Construction of DDX3 mutants
Starting from the full-length cDNA construct, the N-DDX3 (aa 1-427), DDX3DINS (aa 1-249/260-662) and I-DDX3 (aa 160-427) mutants were constructed by PCR. The N-DDX3 mutant (aa 1-427) was obtained using the forward primer 59-ATACG-GATCCTGCATGAGTCATGTGGCAGTG-39 and reverse primer 59-CCCAAGCTTTTTGTCTGATTCTTCCACCCAA-ACTACTTTCTG-39. The double deleted mutant I-DDX3 (aa 160-427) was obtained by PCR using the forward primer 59-GGGGGATCCTTTGAGAAATACGATGACATTCCAGTT-GAG-39 and reverse primer 59-CCCAAGCTTTTTGTCT-GATTCTTCCACCCAAACTACTTTCTG-39. The DINS mutant (D250-259), was obtained by overlap extension gene split PCR, where the fragment coding for aa 1-249 was amplified using the forward primer 59-ATACGGATCCTGCATGAGTCAT-GTGGCAGTG-39 and the reverse primer 59-TGCTAATAC-CAAGGAGATTGGCAAGATGGGCAACAGAAATGC-39, while the fragment coding for aa 260-662 was amplified with the forward primer 59-CCAATCTCCTTGGTATTAGCA-39 and the reverse primer 59-ATCGAAGCTTGTTACCCCACCAGT-CAACC-39. The two resulting fragments had a short region of complementarity at their 39-and 59-ends, respectively and were used in a third PCR reaction with the forward primer 59-ATACGGATCCTGCATGAGTCATGTGGCAGTG-39 and the reverse primer 59-ATCGAAGCTTGTTACCCCACCAGTCA-ACC-39, to generate the desired cDNA for the DINS mutant. PCR conditions for all mutants were: 29 at 95uC followed by 30 cycles of 400 at 95uC, 19 at 55uC, 19300 at 72uC and a final elongation of 10 min at 72uC. The K230E DDX3, with a substitution of the lysine at the position 230 with a glutamic acid, and the DADA DDX3 mutant, with a substitution of the two aspartic acids at positions 328 and 231 for alanines, were purchased from Bio-Fab Research (Rome). All cDNAs were sequenced for confirmation and cloned into the pTrcHisA vector, resulting in the desired protein fused to an N-terminal peptide of ,3 kDa (comprising the 66His tag) and seven additional amino acids (KQGCFGG) at the COOH-terminal part.
Expression and purification of the recombinant proteins
All clones were expressed in E.coli competent cells BL-21 Select 96 (Promega). Small-scale expression experiments were carried out to select the optimal conditions for solubility of the expressed proteins. Cells were grown at 37uC in Luria Broth (LB) to an OD 600 of 0.4. Isopropyl b-D-thiogalactoside (IPTG) was added to a final concentration of 1 mM and growth continued for 5 hours at 37uC. Recombinant proteins were purified through four different chromatographic steps. Cells were lysed for 459 on ice adding 2.5 volumes per gram of pellet of Buffer A (0.1 M NaPO 4 , 0.01 M TrisHCl pH 8, 0.01%, 5 mM NP-40 Imidazole) in the presence of lysozyme (1 mg/ml), protease inhibitors (1:10000 dilution, Sigma) and 1 mM PMSF. The lysate was sonicated 5 times for 100 and the suspension was centrifugated at 300006 g for 1 h159 at 4uC. The supernatant was applied to an affinity FPLC-NiNTA-column, equilibrated with Buffer B (5 mM TrisHCl 2 pH 8, 250 mM NaCl, 5 mM Imidazole, 5% Glycerol). Proteins bound to the column were eluted with a linear gradient (0.005-0.5 M Imidazole) in Buffer B. The presence of the recombinant protein in the collected fractions was checked by staining (Coomassie Blue) and Western blotting with specific anti-DDX3 antibodies (A300-474A and A300-475A, Bethyl) that recognized an epitope at N-terminal domain between residues 1 and 50 and at the C-terminal domain between residues 550 and 600, respectively. For the I-DDX3 mutants we have used anti-His tag polyclonal antibodies (Cell Signaling TECHNOLOGYH). Positive fractions were collected and dialyzed against Buffer C (25 mM TrisHCl pH 7.5, 10 mM NaCl, 5% glycerol and 0.5 mM L-Dithiothreitol (DTT)) at 4uC. Dialyzed fractions were applied to an anion-exchange Mono Q column previously equilibrated with Buffer C and eluted with a linear gradient (0.01-1 M NaCl) in Buffer C containing 1 M NaCl. After SDS-PAGE and Western blot, positive fractions were pooled and dialyzed against Buffer D (50 mM TrisHCl pH 7.5, 10 mM KCl, 0.5 mM DTT, 5%Glyc-erol). Dialyzed fractions were applied to a cation-exchange chromatography (MonoS) column equilibrated with Buffer D and proteins bound were eluted with a linear gradient (0.01-0.5 M KCl) in Buffer D containing 500 mM of KCl. Positive fractions were collected and dialyzed against Buffer C. Dialyzed fractions were applied to a 1-ml hydroxyapatite column equilibrated in Buffer C. Proteins were eluted with a linear gradient (0-0.7 M KPO 4 , pH 7.5) in Buffer C containing 0.7 M KPO 4 pH 7.5. Positive fractions were made 20% glycerol and stored at 280uC.
ATPase activity assays
The ATPase activity was determined, as previously described [15] , by directly monitoring [c-
32 P] ATP hydrolysis by thin-layer chromatography (TLC). A final volume of 10 ml contained: 0.1 mM of the different DDX3 proteins, unless otherwise indicated in the Figures, 0.1 mM [c- 32 P] ATP (3000 Ci/mmol) as tracer, plus 1 mM of cold ATP, unless otherwise stated, and nucleic acids as indicated. Samples were incubated for 5 minutes at 25uC and dotted onto TLC sheets of polyethylenimine cellulose. The products were separated by ascending chromatography with 0.5 M KH 2 PO 4 (pH 3.4). The intensities of the radioactive bands corresponding to ATP and P i were quantified by densitometric scanning with PhosphoImager. For the stimulation of the ATPase activity, the ssDNA oligonucleotide oligo(dT) 20 or the ssRNA oligonucleotide oligo (rU) 20 were used. Time-course experiments were performed under the conditions described above. Samples were taken at different time points and processed as described above.
ATP binding assay
ATP binding assays of DDX3wt and DDX3DINS proteins were performed by UV cross-linking. 20 ml samples containing different amounts of purified proteins were resuspended in reaction buffer (35 mM Tris-acetate pH 8, 70 mM potassium acetate, 5 mM magnesium acetate, 19 mM ammonium acetate, 0.7 mM DTT) containing 7 mCi of [a-33 P]ATP (110TBq/mmol) together with cold ATP up to a final concentration of 0.5 mM. Samples were subjected to UV irradiation (254 nm) for 15 minutes on ice. Samples were boiled 5 minutes at 95uC and separated by SDS-PAGE on a 12% polyacrylamide gel. The gel was exposed in a phosphorimager storage cassette for 16-18 hours and quantified by laser scanning densiometry (Thyphoon-TRIO, GE Healthcare).
Filter binding assay
The affinity of DDX3wt and DDX3DINS proteins for dsDNA was assessed using a filter binding assay. Different amounts of proteins were incubated in reaction buffer (10 mM Hepes pH 7.2, 100 mM KCl, 3 mM MgCl 2 , 5% glycerol, 1 mM DTT, 50 mg/ml salmon sperm DNA). The 18/36 mer dsDNA (labelled at 59-end of one strand with a 6-FAM fluorescent group) concentration was kept fixed at 50 nM. The binding reactions (25 ml) were incubated for 14 15 minutes at 24uC. Assays were performed using the protein-binding Protran BA-85 nitrocellulose membrane. The membrane was extensively washed in washing buffer (10 mM HEPES pH 7.2, 3 mM MgCl 2 , 5% glycerol, 1 mM DTT), and mounted on a 96-well dot-blotter (Bio-Rad). Before and after application of 25 ml of the binding reaction, the membrane was washed with 180 ml of wash buffer. Following the experiment, the membrane was dried and the quantity of bound proteins determined by laser scanning densiometry (Thyphoon-TRIO, GE Healthcare).
Electrophoretic mobility shift assay (EMSA)
The affinity of DDX3wt and DDX3DINS proteins for ssDNA and ssRNA was assessed using the EMSA assays. Different amounts of proteins were transferred to a fresh pre-cooled Eppendorf tube and the reaction volume was increased to 15 ml with protein buffer (25 mM TrisHCl pH 7.5, 0.5 mM DTT, 20% glycerol. 100 mM NaCl). 4 ml of 56 EMSA binding buffer (10% glycerol, 5 mM MgCl 2 , 2.5 mM EDTA pH 8, 50 mM NaCl, 50 mM TrisHCl pH 7.5, 10 mM DTT) was added to the samples, which were incubated on ice for 20 minutes. After this time, 0.05 pmol of ssDNA or ssRNA (labelled at 59-end with a 6-FAM fluorescent group) was added to the reactions and the samples kept on ice for 1 hour. The free-and protein bound-nucleic acids were separated on a non-denaturing polyacrilamide gel (6%), run at a constant 10 V/cm for 2 hours. Substrates and products were quantified by laser scanning densitometry (Thyphoon-TRIO, GE Healthcare).
Helicase Assays
The helicase activity of DDX3wt and mutant forms was monitored by measuring the conversion of a double stranded (ds) DNA or RNA (labelled at the 59-end of one strand with a 6-FAM fluorescent group) into single stranded (ss) nucleic acid. For the RNA helicase assay, a 18/36mer ds RNA oligonucleotide with both 39 and 59-protruding ss ends was used. For the DNA helicase assay, three different dsDNA substrates were used, all of them composed of the same 18mer oligonucleotide 59-FAM labelled and three different 38 mer oligonucleotides with the sequence complementary to the 18 mer at different positions. Annealing of the 18 mer to each of the 38 mer generated the different DNA substrates shown in Reactions were performed in 50 mM TrisHCl pH 7.5, 1 mM DTT, 0.2 mg/ml BSA, 5% glycerol and 1 mM ATP, 10 mM MgCl 2 at 37uC degrees for 109 and stopped by adding EDTA 50 mM pH 8. Products were separated on a native 7% PAGE containing 0.1% (w/v) SDS at 5 W in TBE buffer with 0.1% SDS at 4uC for 2 hours for RNA substrates, 4 hours for DNA substrates. Substrates and products were quantified by laser scanning densitometry (Thyphoon-TRIO, GE Healthcare). For trap-assays, the enzyme and the RNA substrate were incubated on ice for 4 min, in the absence of ATP. Reactions were started by addition of ATP and a 50-fold molar excess (1 mM) of r(A) 40 trap RNA oligonucleotide, followed by incubation at 37uC for the indicated times.
Kinetic analysis
ATPase reactions were performed as described, in the presence of increasing amounts of nucleic acids and variable ATP concentrations. Variations of the initial velocities of the reaction as a function of ATP concentrations in the absence or presence of nucleic acids were analyzed with the equation:
where k cat is the reaction rate, E 0 is the input enzyme concentration, [ATP] is the variable substrate concentration, K m is the apparent affinity for the substrate, n is the sigmoidicity factor, to take into account the apparent positive cooperativity previously observed for DDX3 in response to increasing ATP concentrations [12] . The relative -fold increase in the ATPase velocities 12(v DNA /v) as a function of the nucleic acid concentrations was fitted to the hyperbolic relationship:
where v NA is the apparent velocity of the reaction in the presence of nucleic acid, v is the velocity in its absence, K D is the apparent affinity for the nucleic acid and [NA] is the concentration of the nucleic acid substrate. The symbol K D is used, instead of K m , solely to reflect the fact that the NA is not a reactant (i.e. it is not converted into products) but only a cofactor of the reaction, without implying any assumption on the nature of the microscopic rates contributing to the K D value itself.
Variation of the ATPase reaction as a function of time was fitted to the mixed-exponential equation:
where [P] is the concentration of products (pmols) at any given time point, t is time, A burst is the burst amplitude, k burst is the rate of the exponential phase, k ss is the rate of the steady-state linear phase. The burst amplitude reflects the amount of enzymesubstrate complex reacting in the exponential phase, hence it has the dimension of a concentration. The burst rate is the combined rate of product formation (Pi) and release during the exponential phase, hence the dimensions of a rate constant (s 21 ). Variation of the amount of unwound RNA substrate as a function of time was fitted to a simple exponential equation:
where MAX is the the amount of unwound substrate extrapolated at infinite time, k uw is the apparent rate of unwinding. The eq. dissociation constant for the binding of DDX3 to its substrate ATP or RNA in the absence of catalysis was anlayzed as a function of variable enzyme concentrations according to a simple binding equilibrium:
where 
RNA pull down assay
Talon beads (Dynal) were incubated over night at 4uC with 1 mg of purified DDX3wt or DDX3DINS proteins, respectively. After washing three times, 1 mg of HIV-1Lai genomic RNA, prepared from HIV-1 virions with the QiaAmp viral RNA Mini kit (Qiagen), was added for 2 hours. After 3 washing steps 100 ml H 2 O was added and bound RNA was extracted with the RNAeasy kit (Qiagen). The extracted RNA was analyzed by RT-PCR using random hexamer primers for RT and gag-specific primers for PCR (HIV-1 gag fw: GAGGAAGCTGCAGAATGGG; HIV-1 gag rev:
GGTCCTTGTCTTATGTCCAGAAT-GCTG). PCR conditions were 3 min 95uC followed by 40 cycles of 30 sec 95uC, 30 sec 50uC, 30 sec 72uC, followed by 7 min 72uC. An aliquot of 50% of the input RNA was kept as RT-PCR control and viral HIVC-1 Lai plasmid was used as positive control for PCR. The experiment was performed three times independently.
Selection of peptides by phage display
Three different random peptide phage libraries (PhD-7, PhD-C7, PhD-12, New England Biolabs) were used. For positive selections we used the DDX3 insert peptide (GSGSGS-H H H H H H -GSGSGS-ALRAMKENGR-GSGSGS-EQKLISEE-DL), for negative selections a scrambled version of the DDX3 insert (GSGSGS-HHHHHH-GSGSGS-RKAEGLNARM-GSG-SGS-EQKLISEEDL), each with a His-tag for immobilization and a Myc-tag for detection (tags are in italics, the actual DDX3 peptide sequences in bold). Peptides (1 mg) were coated on TALON beads over night at 4uC. After 6 washes (PBS/0.25% gelatine/0.1%Tween20), 10 ml of each of the original phage libraries were added to the beads and rotated over night at 4uC. After extensive washing, bound phages were eluted by pH shift (0.2 M glycine/HCl, pH 2.2), neutralized with 1 M Tris-HCl (pH 9.1) and used for negative selection as described above. Phage in supernatants after negative selection were amplified in E. coli ER2738, precipitated over night and used for two additional selection rounds. Finally, phages were titered, single clones were picked, amplified and DNA was prepared for sequence analysis.
Peptide inhibition experiments
HelaP4 cells were seeded at 1610 4 cells/well in DMEM (10%FCS, 2% L-glutamine, 1% penicillin/streptamycine) and infected with HIV-1 Lai (MOI of 0.3) over night at 37uC. 24 hours after infection, cells were washed with PBS and different amounts (5, 20 , 50 mM in DMEM) of peptides (DDX3-INS1: SDVPTQV-GGRRRRRRRRR and control: GSGSGS-GGRRRRRRRRR) were added in fresh medium without FCS for 4 hours. Subsequently medium was again supplemented with 10% FCS and cells were incubated for further 24 hours at 37uC. The next day, viral supernatants were collected and titered on Tzm-bl cells in the presence of polybrene (16 mg/ml). 44 hours after infection, supernatants were discarded, cells were washed with PBS, lysed for 10 min at room temperature in harvest buffer (50 mM MES/Tris pH 7.8/10% glycerol/0.1% triton X100/1 mM DTT) and frozen at 280uC. Luciferase activity in the lysates was measured by luminometry (Lumistar Galaxy, BMG Labbiotechnologies Germany).
